This book presents a review on the genes already linked to an increased susceptibility to prostate cancer It addresses also the important issues of the detection of disease spread as early as possible using molecular methods and the identification of the genes, which are involved in the unique environment of the bones where resistance to endrocrine therapy is a major issue.
Prostate Cancer also provides a description of the histopathological changes, which accompany androgen blockade and discusses the potential strategies
Fernand Labrie MD, Ph.D Laval University Hospital, Research Centre Canada
Michael Koutislieris MD, Ph.D Department of Experimental Physiology, Medical School, University of Athens, Athens